I’m a computational biologist and bioengineer whose work spans precision oncology, biodefense, and human performance.

As a co-founder and chief scientific officer at NNOXX—a spin-out from the Harrington Discovery Institute at Case Western—I developed novel digital and molecular biosensors and multi-modal data analysis frameworks, taking a first-to-market technology from concept to commercialization.

Since then, my work has focused on developing computational models to understand cancer evolution and mechanisms of treatment resistance—with the goal of better personalizing therapies for patients—and developing systems to predict clinical symptomatology following novel pathogen, drug, and environmental exposures.

I also serve as a scientific advisor to early-stage health tech and biotechnology companies, providing strategic guidance on biosensor development, biological data analysis—including multiomics, network modeling, and causal inference—and technical due diligence.

You can read about what I’m currently learning, working on, and thinking about on Sequence & Destroy. Additionally, you can reach me at evanpeikon@gmail.com.